Akebia Therapeutics Reports Third Quarter 2021 Financial Results and Highlights Recent Company Milestones

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. ABBV
2. MU
3. SPCX
4. ACN
5. IBM
6. TSLA
7. DPZ
8. NVDA
9. PRIM
10. META

Go back to Akebia Therapeutics Reports Third Quarter 2021 Financial Results and Highlights Recent Company Milestones

Akebia Therapeutics (AKBA) Reports Q3 Net Loss of $59.5M, Cash and Cash Equivalents of $207.2M

November 4, 2021 8:06 AM EDT

Akebia Therapeutics (NASDAQ: AKBA) reported Q3 net loss of $59.5M. Revenue for the quarter came in at $48.8 million versus the consensus estimate of $49.67 million.

For earnings history and earnings-related data on Akebia Therapeutics (AKBA) click here.

... More